Sangamo Therapeutics (0R1D.LSE) Q2 2024 Earnings

May 9Confirmed
Q2 2024
-0.27
-0.25
-0.23
-0.21

Details

Expected EPS
-0.21375
Actual EPS
-0.27
Surprise EPS
-0.06
Surprise Percent
-26.32%

Description

⁨Sangamo Therapeutics⁩ (⁦0R1D.LSE⁩) has reported earnings of ⁦-0.27⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts